JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB259247

Human ZFR knockout HEK-293T cell lysate

Be the first to review this product! Submit a review

|

(0 Publication)

ZFR KO cell lysate available now. KO validated. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, 131 bp deletion in exon4.
1 Images
Sanger Sequencing - Human ZFR knockout HEK-293T cell lysate (AB259247)
  • Sanger seq

Unknown

Sanger Sequencing - Human ZFR knockout HEK-293T cell lysate (AB259247)

Homozygous : 131 bp deletion in exon4

Key facts

Cell type

HEK-293T

Species or organism

Human

Tissue

Kidney

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, 131 bp deletion in exon4.

Product details

Knockout cell lysate achieved by CRISPR/Cas9.

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.

User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.

This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1Kit": { "sellingSize": "1 Kit", "publicAssetCode":"ab259247-1Kit", "assetComponentDetails": [ { "size":"1 x 100 µg", "name":"Human ZFR knockout HEK293T cell lysate", "number":"AB259247-CMP01", "productcode":"" }, { "size":"1 x 100 µg", "name":"Human wild-type HEK293T cell lysate", "number":"AB259247-CMP02", "productcode":"" } ] } } }

Properties and storage information

Gene name
ZFR
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The zinc finger RNA-binding protein commonly known as ZFR functions mechanically as an RNA-binding protein that plays a role in RNA processing and regulation. ZFR with a molecular mass of around 115 kDa contains zinc finger motifs that facilitate its binding to RNA. It is widely expressed across various tissues with significant expression in brain and muscle tissues. ZFR interacts specifically with RNA molecules to influence their stability and processing.
Biological function summary

ZFR regulates several processes related to RNA metabolism including splicing and degradation important for maintaining cellular RNA homeostasis. ZFR also participates as a subunit in larger ribonucleoprotein complexes which are essential for post-transcriptional gene regulation. Its activity in facilitating RNA transport and stability links it to essential cellular processes impacting gene expression at the post-transcriptional level.

Pathways

ZFR engages in regulatory networks that include pathways involved in RNA processing and stabilization. It plays a part in mRNA splicing pathways important for producing mature mRNA molecules from pre-mRNA. This interaction closely relates ZFR to other proteins such as SMN and other splicing factors integrating ZFR into broader gene expression and RNA management networks.

Alterations in ZFR expression or function have links to neurological conditions such as amyotrophic lateral sclerosis (ALS). This link is through the dysregulation of RNA-binding proteins like TDP-43 which ZFR connects with in RNA metabolic pathways affected in ALS. Additionally ZFR-related anomalies also show associations with certain muscular disorders due to its high expression in muscle and its role in RNA processing within these tissues.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com